Industry & Policy News

[UC San Diego Today] Hungarian-American biochemist and researcher Katalin Karikó has been selected by Scripps Institution of Oceanography at UC San Diego as the recipient of the 2023 Nierenberg Prize for Science in the Public Interest.

[BioSpace] The risks of early death in the trials of Johnson & Johnson and Legend Biotech’s Carvykti and Bristol Myers Squibb and 2seventyBio’s Abcema were not a significant concern for the FDA’s Oncologic Drugs Advisory Committee, which voted 11-0 and 8-3 respectively to support the approvals of the CAR-T therapies as earlier lines of treatment for multiple myeloma.

[University of Alberta] Prostate cancer research team including Drs. Roseline Godbout, Adam Kinnaird, and Ron Moore have been awarded a $1.25 million, four-year Alberta Cancer Foundation “Game Changer Grant” to investigate the link between fat metabolism and prostate cancer progression.

[Vall d'Hebron] AcceleRating the Translation of virtual twins towards a pErsonalized Management of fatty lIver patientS (ARTEMIs) was launched on the 1st of January with the aim of making a major leap forward in the management of metabolic associated fatty liver disease.

[The Guardian] Elana Simon was ten years old when she started to experience severe pains in her abdomen. Elana was suffering from fibrolamellar carcinoma, a rare, usually lethal, form of liver cancer.

[UCLA] The American Association for Cancer Research has awarded Dr. Owen Witte, founding director emeritus of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, with the 2024 Award for Outstanding Achievement in Blood Cancer Research.